BD MiniDraw Capillary Blood Collection System with BD MiniDraw SST Capillary Blood Collection Tube
by Becton, Dickinson and Company
510(k) K252378
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK252378 | Date10 Apr 2026 | StatusActive |
Recalls
No FDA recalls found in the data synced 25 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- JKA
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.1675
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The BD MiniDraw Capillary Blood Collection System with BD MiniDraw SST Capillary Blood Collection Tube is a capillary blood collection device designed for the collection, separation, and processing of small blood samples. It is intended for use with capillary blood from adult patients (aged 18 years and older) and includes a serum separator tube (SST) for serum analysis.
This system is supplied as a single-use, non-sterile device for in-vitro diagnostic use, adhering to FDA clearance under 510(k) K252378. The BD MiniDraw SST tube is intended for serum separation and storage of collected blood samples, facilitating transport to laboratory settings for clinical chemistry testing. The device is regulated under the Clinical Chemistry advisory committee classification and is not intended for MRI use.
Other devices from Becton, Dickinson and Company
Questions
AI-generated answers, 18 Sep 2026
What is the BD MiniDraw Capillary Blood Collection System designed for, and who is it intended for?
The BD MiniDraw Capillary Blood Collection System is designed specifically for collecting, separating, and processing small blood samples from adult patients aged 18 years and older. It includes a serum separator tube (SST) to facilitate serum analysis, making it suitable for clinical chemistry testing in laboratory settings.
Is the BD MiniDraw Capillary Blood Collection System sterile, and how is it supplied?
The BD MiniDraw Capillary Blood Collection System is supplied as a single-use, non-sterile device. This means it is intended for one-time use per patient and should not be reused or resterilized. It is packaged for in-vitro diagnostic use, ensuring compatibility with clinical workflows.
What types of blood samples can be processed with this system, and how is the collected sample handled?
This system is designed exclusively for capillary blood collection from adult patients. The included BD MiniDraw SST tube separates serum from the blood sample, allowing for stable storage and transport to laboratories for clinical chemistry testing. The serum separator ensures the sample remains intact for accurate diagnostic analysis.
How is the regulatory status of this device determined, and what advisory committee oversees its classification?
The BD MiniDraw Capillary Blood Collection System holds FDA clearance under 510(k) K252378, classified as substantially equivalent to a predicate device. Its regulatory classification falls under the Clinical Chemistry advisory committee (CH), which reviews submissions for in-vitro diagnostic devices used in chemistry testing. This ensures compliance with FDA standards for diagnostic accuracy and safety.